Freestone Capital Holdings’s Moderna MRNA Stock Holding History

Freestone Capital Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Sell	3,969 -24,952	-86%	-$1.16M	0.01%	517
2025 Q4	$853K	Sell	28,921 -2,990	-9%	-$81.2K	0.03%	261
2025 Q3	$824K	Buy	31,911 +5,028	+19%	+$140K	0.03%	266
2025 Q2	$742K	Sell	26,883 -2,003	-7%	-$52.7K	0.03%	248
2025 Q1	$782K	Buy	+28,886	New	+$1.03M	0.03%	234
2021 Q4	–	Sell	-2,109	Closed	-$315K	–	522
2021 Q3	$315K	Buy	+2,109	New	+$778K	0.02%	340
2021 Q1	–	Sell	-2,410	Closed	-$117K	–	836
2020 Q4	$117K	Buy	2,410 +2,260	+1,507%	+$229K	0.01%	411
2020 Q3	$10.6K	Buy	+150	New	+$10.5K	﹤0.01%	732

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Freestone Capital Holdings's MRNA Position: Q1 2026 in Review

Freestone Capital Holdings reduced its Moderna (MRNA) stake by 86% in Q1 2026, selling an estimated $1.16M and leaving 3,969 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #517.

Freestone Capital Holdings first reported a position in MRNA in Q3 2020 and has held it in 8 quarters since. The position peaked at $853K in Q4 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Freestone Capital Holdings held 3,969 shares of Moderna worth $202K as of Q1 2026.
Freestone Capital Holdings sold 24,952 Moderna shares in Q1 2026, an estimated $1.16M.
Moderna made up 0.01% of Freestone Capital Holdings's portfolio in Q1 2026, its #517 holding.
Freestone Capital Holdings first reported a position in Moderna in Q3 2020 and has held it in 8 quarters since.
Freestone Capital Holdings's Moderna position peaked at $853K in Q4 2025.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.